Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 40.52% vs 33.77% in Sep 2025
Standalone Net Profit
YoY Growth in quarter ended Sep 2026 is -7.39% vs 65.81% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 16.18% vs 12.40% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 87.50% vs 14.29% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Medico Remedies With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 6.59% vs 22.16% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 40.52% vs 33.77% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -5.56% vs -57.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -7.39% vs 65.81% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -4.24% vs -53.85% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 16.18% vs 12.40% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 9.76% vs -54.44% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 87.50% vs 14.29% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025